openPR Logo
Press release

Multiplex Assays Market Growth Overview Along with Company Profiles Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, & Others.

04-26-2019 07:53 PM CET | Health & Medicine

Press release from: Allied Market Research

Multiplex Assays Market Growth Overview Along with Company Profiles Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, & Others.

The global Multiplex Assays Market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022, registering a CAGR of 7.4% during the forecast period 2016-2022. The protein-based multiplex assays segment held over two-thirds share of the total market in 2015. Protein-based multiplex assays are expected to dominate global multiplex assays market during the forecast period, owing to their rise in adoption to analyze unknown proteins and their functions simultaneously and precisely.

Request For PDF Report Sample @ www.alliedmarketresearch.com/request-sample/1921

Multiplex assays are techniques that analyze multiple analytes at the same time. Multiplex assays extract more data from a sample in less time as compared to single-plex assays. The key factors that drive the growth of the market include increase in research & development activities for the detection of biomarkers for various diseases & treatment options of the diseases; rise in adoption of personalized medicine for increasing safety & efficacy of therapies; benefits, such as lower operational cost & reduced labor; and technological advancements. However, shortage of skilled labor and high capital investment are expected to restrain the market growth during the forecast period.

The multiplex assays market in this report is studied on the basis of type, product, technology, application, end user, and geography. Based on type, it is divided into nucleic acid-based multiplex assays, protein-based multiplex assays, and other multiplex assays. Protein-based multiplex assays held highest share over two-thirds in 2015, owing to high usage of multiplex assays for the differentiation of proteins on the basis of their properties in different fields, such as diagnostic clinics, research & development, and others.

By product the market is classified into multiplex assay consumables, multiplex assays instruments & accessories, and multiplex assay software & services. The multiplex assays reagents & consumable market held the highest share of three-fourths in 2015, and is expected to lead the market during the analysis period. Pharmaceuticals &biotechnological companies in end users held the highest market share of multiplex assays market in 2015, and are expected to show the highest growth rate during the analysis period, owing to the extensive use of multiplex assays in the R&D by pharmaceutical and biotechnology companies.

Geographically, the global multiplex assays market is analyzed by four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. North America was the highest revenue contributor with approximately half of the share in 2015, and is attributed to the ample amount of expenditure in healthcare, research & development, well-established healthcare system, and higher demand for technically advanced devices for research work. However, Asia-Pacific is anticipated to grow with the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income & improved healthcare infrastructure.

Get More Information @ www.alliedmarketresearch.com/purchase-enquiry/1921

Key Findings of Multiplex Assays Market

• The multiplex assays reagents & consumable market accounted for the highest market share for product segment in 2015, and is also estimated to grow at the highest CAGR of 7.7% in the analysis period.
• By application, research and development held the highest market share and expected to lead the market during the analysis period.
• U.S. was the highest shareholder in the North American multiplex assays market, accounting for six-sevenths share in 2015.
• China is expected to show the highest growth rate during the analysis period in the Asia-Pacific multiplex assays market.

The key players profiled in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, 2015
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Access Full Summery @ www.alliedmarketresearch.com/multiplex-assays-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplex Assays Market Growth Overview Along with Company Profiles Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, & Others. here

News-ID: 1720390 • Views: 1120

More Releases from Allied Market Research

Current Technological Advancements on Erythropoietin Drugs Market SWOT Analysis …
"Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020", forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects. Download
Flow cytometry market has huge growth at a CAGR of 16.0% during the period 2018 …
The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9%. Increasing needs to enhance precisions and produce faster results as well as need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Download the Sample Report @ http://bit.ly/2Y2dzBI Though popularity has been gained in the application field of life science industry, the
Silane and Silicone Market Analysis & Technological Innovation by Leading Key Pl …
"Silane and Silicone Market, by Type, and End-User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025",The Silane and Silicone market accounted for revenue of $ 14,479.0 million in 2017, and is anticipated to generate revenue of $ 22,030.3 million in 2025. Download the Sample Report @ http://bit.ly/2x5ChFN Silicones are polymers, which comprise silicon along with carbon, oxygen, and hydrogen. The silicon and oxygen bond in silicones is the key reason due
Acrylic Acid Market Key players are Dow Chemical Company, BASF SE, Arkema SA, Th …
The market research conducted by Allied Market Research is projecting the current trends in the applications of acrylic acid market. This report evaluates the acrylic acid market in terms of value ($million) and volume (tons). Download the Sample Report @ http://bit.ly/2MVCMNc Acrylic acid is the essential compound used in surface coating industry that helps in manufacturing of high tensile and thermal resistance materials. Acrylic acid is expected to be the largest

All 11439 Releases


More Releases for Multiplex

Multiplex Assay Market Analysis and Opportunity Assessment 2017-2027
"The Latest Research Report Multiplex Assay Market: Global Industry Analysis and Opportunity Assessment 2017-2027 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay.
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Forecasts Healthy Growth by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising
Multiplex Assay Market Industry Analysis, Trend and Growth, 2017-2027
An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay. The term multiplex refers to the highest number of analyte measurement per assay. Detection of the state of all biomolecules of a given class (i.e. proteins and mRNAs) within a
Global Multiplex Biomarker Imaging Market Research Report 2017
In this report, the global Multiplex Biomarker Imaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Multiplex Biomarker Imaging in these regions, from 2012 to 2022